Elaine Warner

Medical Affairs Lead
Kedrion Biopharma
Fort Lee, New Jersey, United States

Presentation(s):

• PB0229 - DESIGNING THE RYPLAZIM® (PLASMINOGEN, HUMAN-tvmh) ARM OF ATHN TRANSENDS: SAFETY AND EFFECTIVENESS IN PEOPLE WITH PLASMINOGEN DEFICIENCY

  Sunday, June 25, 2023
  18:30 – 19:30 ET